Channel - Med/Surg Telehealth Lectures
8/14/2019 1:08:12 AM

Channel Videos

20121024-Med/Surg:Cancer and Venous Thromboembolism - S. moll - 20121024
Objectives: 1) decide which anticoagulant to use in patients with cancer and acute venous thromboembolism; 2) discuss which patient with asymptomatic venous thromboembolism, discovered on cancer screening radiological testing, should undergo anticoagulation therapy and which one not. 3) list the indications for IVC filter placement and discuss the absolute and relative contraindications; 4) discuss the pros and cons of the new oral anticoagulants.
Stephan Moll MD
10/24/2012 4:00:00 PM
View

Accrual to Cancer Clinical Trials - K. Amos - 20120822
Objectives: • Discuss the importance of clinical trials for cancer care • Describe national statistics on accrual rates to cancer clinical trials • Review types of clinical trials • Identify challenges and barriers to sponsoring clinical trials • Examine barriers to accrual of minorities in cancer clinical trials
Keith Amos MD
8/22/2012 2:45:00 PM
View

Active Surveillance for Prostate Cancer - M. E. Nielsen - 20130828
Objectives: 1. Describe epidemiology of prostate cancer 2. Identify data supporting safety and efficacy of Active Surveillance 3. Recognize components of surveillance program 4. Identify current barriers and areas of uncertainty with respect to active surveillance
Matthew E Nielsen MD, MS, FACS
8/28/2013 4:00:00 PM
View

Acute Myeloid Leukemia: Have We Made Any Progress? J. Zeidner - 20150128
This talk will give us an updated status of the latest research on Acute Myeloid Leukemia (AML). Learning Outcomes: 1. To discuss the epidemiology, pathophysiology and diagnostic testing performed in AML. 2. To discuss the prognostic factors and therapeutic options for AML. 3. To discuss the exciting research horizon in AML. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Joshua Zeidner MD
1/28/2015 4:55:00 PM
View

Advances in Metastatic Prostate Cancer - M. Milowsky - 20160622
This lecture discusses some of the advancements in Metastatic Prostate Cancer such as the use of newer hormonal agents and Docetaxel chemotherapy against castration-sensitive metastatic prostate cancer. Learning Outcomes: • Discuss newer hormonal agents in the management of castration-resistant metastatic prostate cancer. • Examine a new role for Docetaxel chemotherapy in the management of castration-sensitive metastatic prostate cancer. • Compare other novel agents in the management of advanced prostate cancer. This lecture was presented as a part of the Medical and Surgical Oncology Series.
Matthew Milowsky MD
6/22/2016 3:30:00 PM
View

Advances in Neuro Oncology - J. Wu - 20130925
Objectives: 1. Discuss the current standard of care for malignant glinomas and brain metastases 2. Review the progress in the field of neuro-oncology 3. Review the clinical trial portfolio of the UNC Neuro-Oncology Program
Jing Wu MD, PhD
9/25/2013 3:55:00 PM
View

An Overview of Melanoma, with an emphasis on the systemic treatments - F. Collichio - 20141022
This lecture will discuss the causes and prevalance of malignant melanoma and talk about the treatment methods for the different stages. Learning Outcomes: 1. Recognize melanoma skin cancer. 2. Describe broad treatment by stage. 3. Know the different categories of systemic treatment. 4. Manage the side effects of therapy. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Francis Collichio MD
10/22/2014 3:55:00 PM
View

ASCO 2012 Update:Hottest topics in the Treatment of Lung Cancer - J. Weiss - 20120725
Objectives: 1. Identify new treatment methods for lung cancer after initial chemotherapy 2. Discuss optimal treatment of patients with limited functional status 3. Recognize that new molecular targets in NSCLC are adding new treatment options
Jared Weiss MD
7/25/2012 5:17:00 PM
View

Brain Metastases Program - C. Anders and T. Zagar - 20140122
Carey Anders MD
1/22/2014 4:55:00 PM
View

Breast Cancer Update:New Targeted Therapies, Side Effects and Survivorship Issues - C. Dees - 20130724
Objectives: 1. The participant will learn about the benefits of the newest targeted therapies used for the treatment of breast cancer 2. The participant will learn about the side effects of the newest targeted therapies along with strategies to minimize these side effects 3. The participant will learn about the interdisciplinary resources available to deal with survivorship issues related to breast cancer
Claire Dees MD, MSc
7/24/2013 4:00:00 PM
View

Cancer Pain Management - D. L. James - 20160525
This lecture will discuss the epidemiology and pathophysiology of cancer pain and focus on the principles of multimodal analgesia. Dr. James will also elucidate novel therapies in cancer pain management. Learning Outcomes: • Discuss epidemiology and pathophysiology of cancer pain. • Explain principles of multimodal analgesia. • Elucidate novel therapies in cancer pain management. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Dominika L James MD
5/25/2016 3:30:00 PM
View

Choosing Therapy for Melanoma and Managing Side Effects - F. Collichio - 20160323
In this lecture, Dr. Frances Collichio looks at how clinical trials relate to melanoma research from a high-level perspective. She will also discuss the serious side effects of immunotherapy, when it is appropriate to recommend and how to mitigate the side effects. Learning Outcomes: • Examine the big picture of clinical trials and how they relate to melanoma research. • Identify when it is appropriate to recommend immunotherapy. • Evaluate the serious side effects of immunotherapy and their management. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Francis Collichio MD
3/23/2016 3:30:00 PM
View

Comprehensive Assessment of the Geriatric Oncology Patient - T. Jolly - 20130522
Objectives: 1. Understand the value of geriatric assessment in the care of older cancer patients 2. Explain how geriatric assessment can be applied to routine oncology practice 3. Identify how geriatric assessment can guide interventions to improve the outcomes
Trevor Jolly MBBS
5/22/2013 3:55:00 PM
View

Crisis:The Rising Cost of Cancer Care in the United States - T. Khan and B. Muluneh - 20140625
This lecture will discuss the current crisis of rising cancer care costs driving some patients to near bankruptcy. Learning Outcomes: 1. Discuss the current state of increased health care costs in the United States 2. Discuss the impact of increased health care costs on oral chemotherapy non-adherence 3. Propose potential solutions for addressing the financial challenges in cancer care This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Tippu Khan PharmD
6/25/2014 3:55:00 PM
View

Current Treatment Paradigms for Pancreatic Cancer - H. Sanoff - 20140924
The speaker will begin with the basics of pancreatic cancer and symptoms in its early stages. The discussion will continue to the treatment paradigms by advancement of the disease. The lecture will conclude by highlighting new advancements in the treatment of pancreatic cancer. Learning Outcomes: 1. Learn the basics of Pancreatic Cancer 2. Explain treatment paradigms by extent of disease 3. Identify new treatment strategies for Pancreatic Cancer This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Hanna Sanoff MD
9/24/2014 3:55:00 PM
View

Enhancing the Patient Voice in Clinical Care through Patient-Reported Data - B. Reeve - 20151118
A patient's involvement in their own care is critical to their survivorship by improved acceptance of their treatment, greater likelihood of adhering to treatment, and better managing their symptoms. Learn how to improve doctor-patient communication, decision-making, and ultimately health outcomes. Learning Objectives: • Identify the types of patient-reported data that may be relevant for improving quality of care. • Describe the strengths and challenges for integrating patient-reported data into clinical practice settings. • Discuss the role of Health IT to collect, store, and report patient-reported data. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
PhD Bryce Reeve
11/18/2015 4:15:00 PM
View

Evolution of Novel Radiation Strategies to Improve the Therapeutic Ratio - L. Marks - 20130227
Objectives: 1. Explain the role of uncertainty in how radiation therapy is delivered 2. Describe recent advances in radiation therapy and how they are intended to reduce uncertainty 3. Identify the risks of some of the new technologies
Larry Marks MD
2/27/2013 5:00:00 PM
View

Fertility Preservation in Male Oncology Patients - M. Coward - 20150325
This lecture discusses the different scenarios of fertility preservation issues for male oncology patients depending on what stage in life the patient is in. Learning Outcomes: 1. Understand the concept of oncofertility and its importance for young cancer patients 2. Describe how cancer and cancer treatments affect male fertility, and understand all of the methods of fertility preservation, beyond sperm banking, for male patients 3. Know when and who to refer for fertility preservation and how to counsel patients about their options This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Matthew Coward MD
3/25/2015 3:55:00 PM
View

How I Treat Lymphoma - S. Park - 20130424
Objectives: 1. Describe basic information about lymphoma 2. Discuss how lymphoma is diagnosed, classified, and staged 3. Identify new treatments and clinical trials in lymphoma
Steve Park MD
4/24/2013 3:55:00 PM
View

Indications for Cyberknife Radiation - R. Chen - 20120523
Objectives: 1) Describe Cyberknife radiation 2) Discuss potential uses of Cyberknife radiation in different cancers including lung cancer, prostate cancer and treatment of metastatic disease 3) Described published literature demonstrating patient outcomes after Cyberknife treatment
Ron Chen MD, MPH
5/23/2012 4:00:00 PM
View

Late Effects of Childhood Cancer - J. Blatt - 20150722
This lecture will discuss the latent systemic effects for childhood cancer survivors. Dr. Julie Blatt explains how every organ is essentially at risk dependent upon type of treatment, age, and gender. Learning Outcomes: • to recognize the high cure rate in children with cancer • to describe the spectrum of possible late effects • to explain the role of the PCP and dedicated survivorship clinic in monitoring late effects This lecture was presented as a part of the Medical and Surgical Oncology Series.
UNCCN Mediasite Presenter
7/22/2015 3:30:00 PM
View

Lung Cancer Screening - M. P. Rivera - 20152204
This lecture will discuss balancing the risk and benefits of lung cancer screening in asymptomatic, high-risk individuals. Learning Outcomes: 1. Understand the criteria for screening for lung cancer 2. Review the risks and benefits of screening 3. Discuss role of prediction models in screening This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
M. Patricia Rivera MD
4/22/2015 3:40:00 PM
View

Lymphoma: New treatments and clinical trials, including an update from ASH 2011 - K. Richards - 20120222
Objectives: 1. Identify current lymphoma diagnosis and treatment 2. Describe new therapies for lymphoma 3. Discuss clinical trials and therapies development
Kristy Richards PhD
2/22/2012 7:00:00 PM
View

Med/Surg:Genomics and Breast Cancer - C. Perou - 20130123
Objectives: 1. Discuss the basics of genome sequencing based upon short read mapping approach 2. Describe how genome sequencing may be used as a biomarker of response
Chuck Perou PhD
1/23/2013 5:00:00 PM
View

Metastatic Breast Cancer - L. Carey - 20190626
Of women diagnosed with early-stage breast cancer, almost 30% will develop metastatic disease. Genomic testing of metastatic breast cancer will help us determine which forms of breast cancer are likely to return in other parts of the body.
Lisa Carey MD
6/26/2019 3:30:00 PM
View

Neoadjuvant Approaches to Breast Cancer: When, Why and How - L. Carey and D. Ollila - 20141119
This lecture will discuss Neoadjuvant therapy and its advantages in minimizing surgery. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Lisa Carey MD
11/19/2014 4:55:00 PM
View

New Options for Immunotherapy: Where We Are and Where We’re Going - B. Vincent - 20170726
Benjamin Vincent MD
7/26/2017 3:30:00 PM
View

Obesity in Gynecologic Oncology: A Growing Epidemic - P. Gehrig - 20160224
The lecture will discuss the impact that obesity has on the development of gynecologic malignancies and the outcomes of those malignancies. Medical options for treating obesity will also be talked about as a preventative measure. • Discuss the obesity epidemic in the United States. • Assess the impact of obesity on the development of, and outcomes from, gynecologic malignancies. • Compare and contrast the medical options for treating obesity as a preventative measure. This lecture was presented as a part of the Medical and Surgical Oncology Series.
Paola Gehrig MD
2/24/2016 4:30:00 PM
View

Optimizing Care for the Older Cancer Patient - T. Jolly and H. Muss - 20140226
Trevor Jolly MBBS
2/26/2014 4:55:00 PM
View

Pediatric Oncology: Past, Present and Future Directions - S. Gold - 20151028
Dr. Stuart Gold, Chief of Staff of the UNC Pediatric Hematology/Oncology Division will discuss the important principles to understanding childhood cancer including the different types of pediatric cancer, pediatric oncology cooperative groups, ALL advances and the significant role that cytogenetics plays in ALL. Learning Outcomes: • Understand childhood cancer cooperative groups. • Understand childhood acute lymphoblastic leukemia and its treatment. • Understand where pediatric oncology has been and what the future may bring. This lecture was presented as a part of the Medical and Surgical Oncology Series
UNCCN Mediasite Presenter
10/28/2015 3:30:00 PM
View

Psychopharmacology in the Oncology Setting - D. Rosenstein - 20121128
Objectives: 1) Describe and discuss key principles of psychopharmacology 2) Identify the first-line pharmacological treatments for common psychiatric syndromes in patients with cancer 3) Discuss the important safety considerations for using psychotropics in the oncology setting
Donald Rosenstein MD
11/28/2012 5:00:00 PM
View

Recent Advances in Radiation Oncology - A. Wang and M. Eblan - 20150624
This lecture discusses radiation therapy as a key component in the curative regimen for many cancers. The speaker will review new technologies in radiation oncology including Arc therapy, image guidance, and radiosurgery. Learning Outcomes: • Explain current advances in radiation oncology • Describe recent practice changes in radiotherapy for different types of cancers • Identify future developments in radiation oncology, including immunotherapy and nanomedicine This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series
UNCCN Mediasite Presenter
6/24/2015 3:30:00 PM
View

Sarcoma: A Primer on this Motley Crew of Cancers - J. G. Olson - 20131023
Objectives: 1. Describe the general classification of sarcomas 2. Identify the principles of sarcoma evaluation & therapy 3. Describe future directions of sarcoma therapy
Juneko Grilley-Olson MD
10/23/2013 4:00:00 PM
View

Special Considerations for Patients and Mental Illness and Cancer - D. Rosenstein - 20160727
This lecture provides an overview of the critical role behavior has in oncology and discusses how to assess and manage psychiatric symptoms with a focus on suicide in cancer patients. Learning Outcomes: • Identify common challenges faced by psychiatric patients who are treated for cancer. • Describe important drug-interactions with psychotropic medications. • Employ sensitivity to previously traumatized patients. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Donald Rosenstein MD
7/27/2016 3:30:00 PM
View

Stereotactic Body Radiation Therapy for Prostate Cancer - R. Chen - 20140423
Ron Chen MD, MPH
4/23/2014 3:55:00 PM
View

The ABCs of BMT - S. Sharf - 20130626
Objectives: 1. Describe the difference between an autologous and an allogeneic bone marrow/stem cell transplant 2. Identify at least three (3) diseases that could be treated by a bone marrow/stem cell transplant 3. Define at least three (3) barriers to obtaining a suitable allogeneic donor
Sam Sharf RN, BSN, CHTC
6/27/2013 3:55:00 AM
View

The Difficult Patient - J. Johnson - 20150304
This talk will highlight some of the most dreaded patients we see in healthcare, the"Difficult Patient." This patient typically involves ones with substance use disorders or those with personality traits that make them angry, irritable, demanding, condescending, or threatening. This talk will outline ways to think about "difficult patients", providing examples as well as a basic psychological understanding of why certain patients act certain ways. Finally, it will provide behavioral and medical ways for managing difficult patients so that staff feels more comfortable managing these types of people when they are in their clinic or hospital. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Justin Johnson MD
3/4/2015 4:55:00 PM
View

The Impact of Centralization of Major Cancer Surgery - K. Stitzenberg - 20140723
This lecture discusses the advantages of centralizing surgeries in cases of major cancers such as Esophageal and Pancreatic cancers. Learning Outcomes: * To evaluate temporal trends in the mortality and concentration of high-risk oncological procedures. * To assess the risk/benefit ratio for centralization of major cancers such as Esophageal and Pancreatic cancers. This lecture was presented as a Medical Surgical Oncology Lecture Series.
Karyn Stitzenberg MD, MPH
7/23/2014 3:55:00 PM
View

The Odyssey of Cancer Pain in Women - D. Zolnoun - 20140326
Objectives: 1. Develop a framework for inquiry into urogenital symptoms 2. Provide symptoms-based palliative treatment regimen for patients with urogenital symptoms undergoing chemo/radiation therapy
Denniz Zolnoun MD, MPH
3/26/2014 3:55:00 PM
View

The Problem of Suicide in the Oncology Setting - D. Rosenstein - 20140528
This lecture will discuss the topic of suicide within the cancer patient population and how while its often difficult to predict, clinicians can assess risk and screen for suicidal ideation and respond accordingly. Learning Outcomes: * Overview of risk and protective factors * Recognize that the patient at-risk for suicide is relevant to all clinicians. * Learn the different components that go into screening for Suicide This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Donald Rosenstein MD
5/28/2014 3:55:00 PM
View

Treatment of Advanced and Recurrent Rectal Cancer - B. Calvo - 20131120
Benjamin Calvo MD
11/20/2013 4:55:00 PM
View

Update in Breast Cancer Imaging & Molecular Classification - C. Kuzmiak - 20150923
This lecture will discuss and compare the various methods of breast imaging for screening and diagnostic assessment. The speaker will also explain the image finding characteristic of each major molecular subtype of breast cancer and their targeted therapies. Learning Outcomes: • Explain the benefits & limitations of 2D & 3D mammography, whole breast ultrasound and magnetic resonance imaging - individually and when used in combination. • Compare & contrast the imaging findings characteristic of each major molecular subtype of breast cancer. • Recognize the importance of the molecular classification of breast cancer with targeted therapies and overall survival outcome. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
UNCCN Mediasite Presenter
9/23/2015 3:30:00 PM
View

Update on Advanced Bladder Cancer - M. Milowsky - 20120328
Objectives: 1. Explain the management of patients with locally advanced/metastatic urothelial carcinoma of the bladder. 2. Discuss the treatment of patients with advanced bladder cancer who are ineligible for cisplatin-based chemotherapy. 3. Describe the use of perioperative chemotherapy in the management of patients with muscle-invasive bladder cancer including a discussion of the underutilization of neoadjuvant chemotherapy.
Matt Milowsky MD
3/28/2012 4:00:00 PM
View

Update on Colorectal Cancer: Current Treatment Strategies and Clinical Trials - A. McRee - 20120425
Objectives 1. Describe epidemiology and staging of colorectal cancer 2. Identify adjuvant therapy and mismatch repair status 3. Describe treatment strategies including new therapeutic targets and clinical trials
Autumn McRee MD
4/25/2012 9:00:00 PM
View

Updates in Breast Cancer Epidemiology and Pathogenesis - M. Troester - 20160427
This lecture will discuss the latest research in the scope of epidemiology and pathology to gain a better understanding of both the survivorship and causes of breast cancer. Dr. Troester will focus on mortality disparities in races and the research challenges for resolving these disparities. Learning Outcomes: • Describe the subtypes of breast cancer and how they are identified with tissue biomarkers. • Illustrate differences in risk factor and survivorship profiles for breast cancer subtypes. • Describe racial disparities in incidence and mortality from cancer and highlight remaining research challenges for understanding and resolving disparities. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Melissa Troester PhD
4/27/2016 3:30:00 PM
View

Updates in Gynecologic Oncology - W. Brewster - 20150826
This lecture will discuss the prevalence of gynecological cancers in the US and the role that obesity plays in these numbers. The discussion will also review the surgical, chemotherapy, and biological options for epithelial ovarian cancer and recurrent endometrial cancer. Learning Outcomes: • Discuss surgical therapies for gynecologic malignancies • Describe chemotherapy and radiation options for gynecologic malignancies • Identify new developments in genetics This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
UNCCN Mediasite Presenter
8/26/2015 3:30:00 PM
View

Updates in Interventional Pulmonology - J. Akulian - 20140827
This lecture will discuss what Interventional Pulmonology is, including the subtexts of advanced diagnostic bronchoscopy and therapeutic bronchoscopy. Learning Outcomes: * What is Interventional Pulmonology? * Discuss the symptoms of Central Airway Obstruction * Discuss the advantages of diagnostic bronchoscopy. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Jason Akulian MD, MPH
8/27/2014 3:55:00 PM
View

Updates in Lung Cancer from ASCO 2016 - J. Weiss - 20160824
This lecture provides a review of 2016 updates from the American Society of Clinical Oncology and includes recognizing new treatment plans for patients with lung cancer, how intensive follow-up can improve the quality of life and survival for thoracic oncology patients, and using American Joint Committee on Cancer (AJCC) in treatment planning. Learning Outcomes: • Recognize new treatments that are available for metastatic lung cancer, localized lung cancer, and small cell lung cancer. • Describe the role that intensive follow-up can play in improving quality of life and survival for thoracic oncology patients. • Discuss use of American Joint Committee on Cancer (AJCC) in treatment planning to ensure appropriate prognostic indicators and evidence-based national guidelines are used when developing treatment plans for thoracic oncology patients. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Jared Weiss MD
8/24/2016 3:30:00 PM
View

Updates in Melanoma treatment for patients with advanced disease - F. Collichio - 20120926
Objectives: 1. Identify and describe the different options for therapy for advanced melanoma 2. Describe side effects of melanoma treatment and discuss interventions to manage them 3. Describe why melanoma is still a devastating disease and the continued need for more research into this disease
Francis Collichio MD
9/26/2012 4:00:00 PM
View

Which Patients to Refer for Stem Cell Transplantation and When - T. Shea - 20131009
Objectives: 1. Discuss the current data on outcomes of stem cell transplant in various diseases 2. Identify which patients are best suited for transplant referral 3. Describe the optimal time to refer patients for evaluation for stem cell transplantation
Thomas Shea MD, Director of the UNC Cancer Network
10/9/2013 4:00:00 PM
View

Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform
Mediasite
Sonic Foundry